Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

释瑞达 - NMPA Drug Approval Details

Approvals/NMPA/Serrapeptase Enteric-coated Tablets

Approved

化学药品

Serrapeptase Enteric-coated Tablets

Unknown🇨🇳 National Medical Products Administration

Approval Date: Jan 5, 2026
Approval ID: 887le4Q3D3d
Company: Unknown
Type: 化学药品

Approval Details

Approval Id: 887le4Q3D3d
Approval Number: 国药准字HC20160010
Generic Name: 舍雷肽酶肠溶片
Generic Name En: Serrapeptase Enteric-coated Tablets
Trade Name: 释瑞达
Brand Name: 释瑞达
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 10mg/片(相当于舍雷肽酶20000单位)
Reg Date: 2026-01-05
Expired Date: 2031-01-04
Production Company Address: 台中市工业区23路21号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 5, 2026

Approval ID

887le4Q3D3d

Type

化学药品

Back to NMPA Approvals